Concentrix (CNXC) CEO Christopher Caldwell adds 1,000 shares in open‑market buy

Rhea-AI Filing Summary

Concentrix Corp President and CEO Christopher A. Caldwell reported buying additional company stock in an open-market transaction. On January 29, 2026, he purchased 1,000 shares of Concentrix common stock at a price of $37.07 per share, coded as a purchase transaction.

Following this trade, Caldwell beneficially owned 362,075 shares of Concentrix common stock, held in direct ownership. This filing reflects an increase in his personal equity stake and aligns his financial interests further with those of other shareholders.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caldwell Christopher A

(Last) (First) (Middle)

39899 BALENTINE DRIVE

SUITE 235

(Street)

NEWARK CA 94560

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Concentrix Corp [ CNXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/29/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/29/2026		P		1,000	A	$37.07	362,075	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Andrew A. Farwig, Attorney-in-Fact	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Concentrix (CNXC) report for its CEO?

Concentrix reported that President and CEO Christopher A. Caldwell bought 1,000 shares of common stock. The open‑market purchase occurred on January 29, 2026, and was reported on a Form 4 insider trading filing with the SEC.

At what price did the Concentrix (CNXC) CEO buy shares on January 29, 2026?

Christopher A. Caldwell purchased Concentrix common stock at $37.07 per share. The transaction involved 1,000 shares and was classified as a code “P” open‑market or private purchase under SEC reporting rules for insiders.

How many Concentrix (CNXC) shares does CEO Christopher Caldwell own after this trade?

After the January 29, 2026 purchase, Christopher A. Caldwell beneficially owned 362,075 Concentrix common shares. The Form 4 indicates these shares are held with direct ownership, reflecting his personal stake in the company’s equity.

What does transaction code “P” mean in the Concentrix (CNXC) Form 4 filing?

Transaction code “P” in the Concentrix Form 4 shows the CEO engaged in a purchase of common stock. It designates an open‑market or private buy, distinguishing it from option exercises, sales, or other types of insider transactions.

Who filed the January 29, 2026 Concentrix (CNXC) insider transaction?

The filer is Christopher A. Caldwell, President and CEO and a director of Concentrix Corp. He reported his purchase of 1,000 common shares and his updated beneficial ownership of 362,075 shares on a Form 4 submitted to the SEC.